We basically looked at stage distribution at diagnosis for the women who lived in these jurisdictions that had organized programs and those that didn't. What we saw was significantly more stage 1, less stage 2, less stage 3 and less stage 4 for women in their forties if there was screening. They had more earlier breast cancer and less advanced cancer. In their fifties we saw a knock-on effect. Stage 2 and stage 3 were significantly greater if there was no screening in their forties.
On December 6th, 2023. See this statement in context.